Suter W, Jaeger I
Mutat Res. 1982 Feb;97(1):1-18. doi: 10.1016/0165-1161(82)90015-2.
The aim of the present study was to evaluate the usefulness of different pairs of DNA repair-deficient and DNA repair-proficient bacterial tester strains in a mutagenicity/carcinogenicity screen, possibly as complements to the Ames test. 70 carcinogenic and non-carcinogenic compounds, representing a variety of chemical structures, were tested for their DNA-damaging effects, using 6 different DNA-repair-deficient bacterial strains. 2 Bacillus subtilis systems, H17/M45 and HLL3g/HJ-15, were used. The susceptibility of Escherichia coli AB1157 was compared with the susceptibility of 4 recombination-deficient mutants, JC5547, JC2921, JC2926 and JC5519. The test compounds were applied onto paper disks (spot test, ST), or incorporated into a top agar layer (agar-incorporation test, AT). The 2 B. subtilis systems were generally found to be more sensitive and reliable than the assays using E coli. The incorporation of the test compounds in the agar increased the sensitivity of the test for polycyclic aromatic hydrocarbons and other poorly water-soluble compounds. Hydrazines and several other highly polar chemicals could be tested more efficiently when applied onto paper disks. About 30% of the test compounds did not induce any growth inhibition and so could not be tested properly. In order to evaluate the ability of these DNA-repair tests to complement the Ames Salmonella mutagenicity test in a genetic toxicology screening program, results from this study were compared with published data both on mutagenicity in the Ames test and on carcinogenicity. 8 carcinogens generally found to be non-mutagenic for Salmonella were tested: 2 showed DNA-damaging properties (mitomycin C, 1,2-dimethylhydrazine), 5 failed to do so (actinomycin D, griseofulvin, thioacetamide, diethylstilbestrol, safrole), and one (thiourea) was not toxic, so that no classification was possible. 2 non-carcinogenic bacterial mutagens were examined; one, sodium azide, was equitoxic for repair-proficient and -deficient strains, while the other, nitrofurantoin, primarily inhibited repair-deficient strains. The DNA-repair tests failed to indicate the mutagenic and carcinogenic properties of acridine orange. Nalidixic acid, a non-mutagenic DNA synthesis inhibitor, damaged bacterial DNA. Apart from the differences summarized above, carcinogenicity was indicated correctly by the Salmonella S9 assay and most sets of DNA-repair-deficient and DNA-repair-proficient tester strains evaluated in this study. Thus, several more carcinogens could be detected by performing the Ames test and the bacterial DNA-repair tests in tandem than by using either test alone. Nevertheless, the use of both bacterial in vitro systems in a battery of short-term tests for mutagenicity/carcinogenicity evaluation is not considered to be ideal, since the Ames test and the pairs of DNA-repair-deficient and DNA-repair-proficient tester strains used had several shortcomings in common under the conditions of this study.
本研究的目的是评估不同对的DNA修复缺陷型和DNA修复 proficient细菌测试菌株在致突变性/致癌性筛选中的有用性,可能作为艾姆斯试验的补充。使用6种不同的DNA修复缺陷型细菌菌株,对70种代表各种化学结构的致癌和非致癌化合物进行了DNA损伤效应测试。使用了2种枯草芽孢杆菌系统,即H17/M45和HLL3g/HJ - 15。将大肠杆菌AB1157的敏感性与4种重组缺陷型突变体JC5547、JC2921、JC2926和JC5519的敏感性进行了比较。测试化合物应用于纸片(斑点试验,ST),或掺入顶层琼脂层(琼脂掺入试验,AT)。一般发现2种枯草芽孢杆菌系统比使用大肠杆菌的试验更敏感和可靠。将测试化合物掺入琼脂中增加了对多环芳烃和其他水溶性差的化合物的测试敏感性。当应用于纸片时,肼类和其他几种高极性化学物质可以更有效地进行测试。约30%的测试化合物未诱导任何生长抑制,因此无法进行适当测试。为了评估这些DNA修复试验在遗传毒理学筛选程序中补充艾姆斯沙门氏菌致突变性试验的能力,将本研究的结果与已发表的关于艾姆斯试验中的致突变性和致癌性的数据进行了比较。对8种通常被发现对沙门氏菌无致突变性的致癌物进行了测试:2种显示出DNA损伤特性(丝裂霉素C、1,2 - 二甲基肼),5种未显示(放线菌素D、灰黄霉素、硫代乙酰胺、己烯雌酚、黄樟素),1种(硫脲)无毒,因此无法分类。检查了2种非致癌细菌诱变剂;一种,叠氮化钠,对修复 proficient和缺陷菌株具有同等毒性,而另一种,呋喃妥因,主要抑制修复缺陷菌株。DNA修复试验未能表明吖啶橙的致突变性和致癌性。萘啶酸,一种非致突变性DNA合成抑制剂,损伤细菌DNA。除了上述总结的差异外,沙门氏菌S9试验以及本研究中评估的大多数DNA修复缺陷型和DNA修复 proficient测试菌株组正确地表明了致癌性。因此,通过串联进行艾姆斯试验和细菌DNA修复试验比单独使用任何一种试验能检测到更多的致癌物。然而,在一系列用于致突变性/致癌性评估的短期试验中使用这两种细菌体外系统并不被认为是理想的,因为在本研究条件下,艾姆斯试验以及所使用的DNA修复缺陷型和DNA修复 proficient测试菌株对有几个共同的缺点。